Armata Pharmaceuticals (ARMP) Preferred Shares (2013 - 2014)

Armata Pharmaceuticals (ARMP) reported Preferred Shares of $87000.0 for Q3 2014, little changed sequentially from $87000.0 in Q2 2014.

Armata Pharmaceuticals (ARMP) Preferred Shares (2013 - 2014) Analysis & Trends

Armata Pharmaceuticals (ARMP) has 2 years of Preferred Shares data on file, last reported at $87000.0 in Q3 2014.

For the quarter ending Q3 2014, Preferred Shares changed N/A year-over-year to $87000.0; the trailing twelve-month figure through Sep 2014 stood at $87000.0 (changed N/A YoY), and the FY2013 full-year result was $89000.0, changed N/A from the prior year.
Preferred Shares steadied at $87000.0 in Q3 2014, from $87000.0 in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $89000.0 in Q4 2013 to a low of $87000.0 in Q2 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Armata Pharmaceuticals	191.29 Mn	186.49 Mn	-	-

Download Data